Optimus Pharma gets nod for Molnupiravir Phase III trials, Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

The company said that the trials will be conducted on as many as 2500 Covid-19 patients suffering from mild and moderate symptoms. The drug will be administered for a period of five days to the volunteers., The company said that the trials will be conducted on as many as 2500 Covid-19 patients suffering from mild and moderate symptoms. The drug will be administered for a period of five days to the volunteers., , Read More